89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,167,283 | +24.4% | 642,073 | 0.0% | 0.21% | +15.1% |
| Q1 2023 | $9,778,772 | +4.4% | 642,073 | -10.4% | 0.18% | +49.2% |
| Q4 2021 | $9,367,000 | -58.0% | 716,670 | -37.0% | 0.12% | -59.2% |
| Q3 2021 | $22,276,000 | +4.8% | 1,137,092 | 0.0% | 0.29% | +2.8% |
| Q2 2021 | $21,264,000 | -29.2% | 1,137,092 | -10.4% | 0.29% | -35.7% |
| Q1 2021 | $30,039,000 | +41.8% | 1,268,539 | +46.0% | 0.44% | +36.9% |
| Q4 2020 | $21,178,000 | +22.3% | 869,000 | +28.7% | 0.32% | -4.1% |
| Q3 2020 | $17,321,000 | +51.1% | 675,000 | +17.4% | 0.34% | +36.1% |
| Q2 2020 | $11,460,000 | +29.7% | 575,000 | +64.3% | 0.25% | -12.9% |
| Q1 2020 | $8,838,000 | -4.0% | 350,000 | 0.0% | 0.29% | +10.4% |
| Q4 2019 | $9,202,000 | – | 350,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |